Biopolymers 2011
DOI: 10.1002/9781118164792.ch1
|View full text |Cite
|
Sign up to set email alerts
|

Hyaluronic Acid: A Natural Biopolymer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
1

Year Published

2013
2013
2016
2016

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 128 publications
0
15
0
1
Order By: Relevance
“…This has forced, for instance, the Baxter Healthcare Corp. (as well as many other companies) to recall many preparations of contaminated heparin [24] and significantly enhanced the interest in detailed heparin analysis [25] to monitor the presence of harmful components [26]. Not least, this is a convincing proof of the pharmacological activities of GAG [27].…”
Section: Chemical Structures Of Native Gagmentioning
confidence: 99%
“…This has forced, for instance, the Baxter Healthcare Corp. (as well as many other companies) to recall many preparations of contaminated heparin [24] and significantly enhanced the interest in detailed heparin analysis [25] to monitor the presence of harmful components [26]. Not least, this is a convincing proof of the pharmacological activities of GAG [27].…”
Section: Chemical Structures Of Native Gagmentioning
confidence: 99%
“…The typical composition of these gels (for example Hyalgan, Ostenil-Tendon, SportVis, Synvisc, Synocrom) is an isotonic solution (150 mM NaCl, pH ~7.3 adjusted by buffer) containing 1% of sodium hyaluronate. There are several problems with this treatment, for example the rapid enzymatic degradation of HyA within the joints [31], the pain and the risk of infection during the injection procedure. Furthermore, during movement and under the weight of the patient's body, the synovial fluid could be squeezed outside the joints reducing the efficiency of the intra-articular treatments.…”
Section: Introductionmentioning
confidence: 99%
“…Our research group has already used sodium hyaluronate as a viscosity-increasing and mucoadhesive component in a nasal formulation (Horvát el al., 2009). Due to the mucoadhesive properties of this biopolymer, sodium hyaluronate can enhance the permeability of drugs via mucosal tissues by increasing residence time on the site of absorption (Lim et al, 2000;Cho et al, 2003;Ludwig, 2005;Schiller et al, 2011).…”
Section: Nasal Delivery Of Drugs To the Systemic Circulation -Generalmentioning
confidence: 99%